Preparation of stable single-chain trimers engineered with peptide, β2 microglobulin, and MHC heavy chain

Current Protocols in Immunology

Volumn , Issue SUPPL. 87, 2009, Pages

  Hansen, Ted ^a   Yu, Y Y Lawrence ^a   Fremont, Daved H ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Lymphocyte development; Recombinant MHC peptide complexes; Tetramers; Vaccines

Indexed keywords

BETA 2 MICROGLOBULIN; DNA VACCINE; IMMUNOGLOBULIN HEAVY CHAIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PEPTIDE; REAGENT; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY;

ANTIBODY ENGINEERING; ANTIBODY PRODUCTION; ANTIGEN SPECIFICITY; ARTICLE; CD8+ T LYMPHOCYTE; CHEMICAL PROCEDURES; HUMAN; LYMPHOCYTOPOIESIS; MOLECULAR PROBE; NONHUMAN; PRIORITY JOURNAL; SINGLE CHAIN TRIMER; STAINING;

AMINO ACID SEQUENCE; ANIMALS; BETA 2-MICROGLOBULIN; CELL LINE; CHROMATOGRAPHY, GEL; DISULFIDES; ELECTROPHORESIS, POLYACRYLAMIDE GEL; H-2 ANTIGENS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA-A ANTIGENS; HUMANS; MICE; MODELS, MOLECULAR; PEPTIDES; PROTEIN CONFORMATION; PROTEIN ENGINEERING; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; T-LYMPHOCYTES; TRANSFECTION;

EID: 70549088931     PISSN: 19343671     EISSN: 1934368X     Source Type: Journal    
DOI: 10.1002/0471142735.im1705s87     Document Type: Article

References (29)

1. Bloch, K.D. 1995. Mapping by multiple endonuclease digestions. Curr. Protoc. Mol. Biol. 13:3.2.1-3.2.5.
2. Choudhuri, K., Wiseman, D., Brown, M.H., Gould, K., and van der Merwe, P.A. 2005. T-cell receptor triggering is critically dependent on the dimensions of its peptide-MHC ligand. Nature 436:578-582.
3. Crew, M.D., Cannon, M.J., Phanavanh, B., and Garcia-Borges, C.N. 2005. An HLA-E single chain trimer inhibits human NK cell reactivity towards porcine cells. Mol. Immunol. 42:1205-1214.
4. Fremont, D.H., Hendrickson, W.A., Marrack, P., and Kappler, J. 1996. Structures of an MHC class II molecule with covalently bound single peptides. Science 272:1001-1004.
5. Fremont, D.H., Stura, E.A., Matsumura, M., Peterson, P.A., and Wilson, I.A. 1995. Crystal structure of an H-2Kb-ovalbumin peptide complex reveals the interplay of primary and secondary anchor positions in the major histocompatibility complex binding groove. Proc. Natl. Acad. Sci. U.S.A. 92:2479-2483.
6. Greten, T.F., Korangy, F., Neumann, G., Wedemeyer, H., Schlote, K., Heller, A., Scheffer, S., Pardoll, D.M., Garbe, A.I., Schneck, J.P., and Manns, M.P. 2002. Peptidebeta2- microglobulin-MHC fusion molecules bind antigen-specific T cells and can be used for multivalent MHC-Ig complexes. J. Immunol. Methods 271:125-135.
7. Hirel, P.H., Schmitter, M.J., Dessen, P., Fayat, G., and Blanquet, S. 1989. Extent of N-terminal methionine excision from Escherichia coli proteins is governed by the side-chain length of the penultimate amino acid. Proc. Natl. Acad. Sci. U.S.A. 86:8247-8251.
8. Huang, C.H., Peng, S., He, L., Tsai, Y.C., Boyd, D.A., Hansen, T.H., Wu, T.C., and Hung, C.F. 2005. Cancer immunotherapy using a DNA vaccine encoding a single-chain trimer of MHC class I linked to an HPV-16 E6 immunodominant CTL epitope. Gene Ther. 12:1180-1186.
9. Hudrisier, D., Riond, J., Garidou, L., Duthoit, C., and Joly, E. 2005. T cell activation correlates with an increased proportion of antigen among the materials acquired from target cells. Eur. J. Immunol. 35:2284-2294.
10. Hung, C.F., Calizo, R., Tsai, Y.C., He, L., and Wu, T.C. 2007. A DNA vaccine encoding a single-chain trimer of HLA-A2 linked to human mesothelin peptide generates anti-tumor effects against human mesothelin-expressing tumors. Vaccine 25:127-135.
11. Ignatowicz, L., Kappler, J., and Marrack, P. 1996. The repertoire of T cells shaped by a single MHC/peptide ligand. Cell 84:521-529.
12. Jaramillo, A., Narayanan, K., Campbell, L.G., Benshoff, N.D., Lybarger, L., Hansen, T.H., Fleming, T.P., Dietz, J.R., and Mohanakumar, T. 2004. Recognition of HLA-A2-restricted mammaglobin-A-derived epitopes. Breast Cancer Res. Treat. 88:29-41.
13. Kim, S., Poursine-Laurent, J., Truscott, S.M., Lybarger, L., Song, Y.J., Yang, L., French, A.R., Sunwoo, J.B., Lemieux, S., Hansen, T.H., and Yokoyama, W.M. 2005. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 436:709-713.
14. Kozono, H., White, J., Clements, J., Marrack, P., and Kappler, J. 1994. Production of soluble MHC class II proteins with covalently bound single peptides. Nature 369:151-154.
15. Lybarger, L., Yu, Y.Y., Miley, M.J., Fremont, D.H., Myers, N., Primeau, T., Truscott, S.M., Connolly, J.M., and Hansen, T.H. 2003. Enhanced immune presentation of a single chain major histocompatibility complex class I molecule engineered to optimize linkage of a C-terminally extended peptide. J. Biol. Chem. 278:27105-27111.
16. Mitaksov, V., Truscott, S.M., Lybarger, L., Connolly, J.M., Hansen, T.H., and Fremont, D.H. 2007. Structural engineering of pMHC reagents for T Cell vaccines and diagnostics. Chem. Biol. 14:909-922.
17. Mottez, E., Langlade-Demoyen, P., Gournier, H., Martinon, F., Maryanski, J., Kourilsky, P., and Abastado, J.P. 1995. Cells expressing a major histocompatibility complex class I molecule with a single covalently bound peptide are highly immunogenic. J. Exp. Med. 181:493-502.
18. Otten, G.R., Bikoff, E., Ribaudo, R.K., Kozlowski, S., Margulies, D.H., and Germain, R.N. 1992. Peptide and beta 2-microglobulin regulation of cell surface MHC class I conformation and expression. J. Immunol. 148:3723-3732.
19. Oved, K., Lev, A., Noy, R., Segal, D., and Reiter, Y. 2005. Antibody-mediated targeting of human single-chain class IMHC with covalently linked peptides induces efficient killing of tumor cells by tumor or viral-specific cytotoxic T lymphocytes. Cancer Immunol. Immunother. 54:867-879.
20. Palmowski, M.J., Parker, M., Choudhuri, K., Chui, C., Callan, M.F.C., van der Merwe, P.A., Cerundolo, V., and Gould, K.G. 2009. A single chain H-2Db molecule presenting an influenza virus epitope shows enhanced ability at stimulating CD8+ T cell responses in vivo. J. Immunol. 182:4565-4571
21. Porgador, A., Yewdell, J.W., Deng, Y., Bennink, J.R., and Germain, R.N. 1997. Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody. Immunity. 6:715-726.
22. Primeau, T., Myers, N.B., Yu, Y.Y., Lybarger, L., Wang, X., Truscott, S.M., Hansen, T.H., and Connolly, J.M. 2005. Applications of major histocompatibility complex class I molecules expressed as single chains. Immunol. Res. 32:109-122.
23. Truscott, S.M., Lybarger, L., Martinko, J.M., Mitaksov, V.E., Kranz, D.M., Connolly, J.M., Fremont, D.H., and Hansen, T.H. 2007. Disulfide bond engineering to trap peptides in the MHC class I binding groove. J. Immunol. 178:6280-6289.
24. Truscott, S.M., Wang, X., Lybarger, L., Biddison, W.E., McBerry, C., Martinko, J.M., Connolly, J.M., Linette, G.P., Fremont, D.H., Hansen, T.H., and Carreno, B.M. 2008. Human major histocompatibility complex (MHC) class I molecules with disulfide traps secure diseaserelated antigenic peptides and exclude competitor peptides. J. Biol. Chem. 283:7480-7490.
25. Uger, R.A. and Barber, B.H. 1998. Creating CTL targetswith epitope-linked beta 2-microglobulin constructs. J. Immunol. 160:1598-1605.
26. Vest, H.N., Ostergaard, P.L., Stryhn, A., and Buus, S. 2001. Phage display of peptide/major histocompatibility class I complexes. Eur. J. Immunol. 31:32-38.
27. White, J., Crawford, F., Fremont, D., Marrack, P., and Kappler, J. 1999. Soluble class I MHC with beta2-microglobulin covalently linked peptides: Specific binding to a T cell hybridoma. J. Immunol. 162:2671-2676.
28. Yu, Y.Y., Netuschil, N., Lybarger, L., Connolly, J.M., and Hansen, T.H. 2002. Cutting edge: Single-chain trimers of MHC class I molecules form stable structures that potently stimulate antigen-specific T cells and B cells. J. Immunol. 168:3145-3149.
29. Zhang, Y., Li, S., Shan, M., Pan, X., Zhuang, K., He, L., Gould, K., and Tien, P. 2007. Hepatitis B virus core antigen epitopes presented by HLA-A2 single-chain trimers induce functional epitope-specific CD8+ T-cell responses in HLA-A2.1/Kb transgenic mice. Immunology 121:105-112.